Market Tracker

05/27 5:16pm ET

Juniper Pharmaceuticals Inc (NASDAQ:JNP)

6.91
Delayed Data
As of May 27
 -0.02 / -0.29%
Today’s Change
5.30
Today|||52-Week Range
15.44
-32.91%
Year-to-Date
Cardiome Pharma (CRME) Jumps: Stock Moves 8.1% Higher
May 23 / Zacks.com - Paid Partner Content
Dermira (DERM) in Focus: Stock Gains 8.7% in Session
May 17 / Zacks.com - Paid Partner Content
Alcobra (ADHD) Catches Eye: Stock Adds 6.3% in Session
May 20 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close6.93
Today’s open6.89
Day’s range6.77 - 6.97
Volume10,185
Average volume (3 months)24,293
Market cap$74.6M
Dividend yield--
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-174.07%
Earnings growth (this year)+51.67%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+15.69%
P/E ratioNM
Price/Sales2.95
Price/Book1.89

Competitors

 Today’s
change
Today’s
% change
NVLSNivalis Therapeutics...+0.11+2.36%
CHMAChiasma Inc+0.08+2.65%
CPIXCumberland Pharmaceu...-0.02-0.44%
LIFEaTyr Pharma Inc+0.02+0.62%
Data as of 4:00pm ET, 05/27/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$37.6M
Annual profit (last year)-$2.1M
Net profit margin-5.68%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Frank C. Condella
Chief Operating Officer &
Director
Nikin Patel
Corporate headquarters
Boston, Massachusetts

Forecasts